Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Rexford Industrial Announces Dates for Fourth Quarter 2024 Earnings Release and Conference Call
-
Yext to Present at Upcoming Investor Conferences
-
Tyson Foods Announces First Quarter Earnings Conference Call and Webcast
-
The AZEK Company Announces Chief Financial Officer Transition and Internal Promotions
-
Lam Research Corporation Announces December Quarter Financial Conference Call
-
Ichor to Present at the 27th Annual Needham Growth Conference
-
Exelixis to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
-
Mission Produce® to Participate in the 2025 ICR Conference
-
Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Zeta Global Appoints Pamela Lord as President of Customer Relationship Management, Strengthening its Leadership in AI-Powered Marketing
-
SkyWater Technology to Present at the 27th Annual Needham Growth Conference
-
Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Agree Realty Announces 2024 Investment Activity & 2025 Investment Outlook
-
OneSpaWorld Announces Participation in the ICR Conference 2025
-
Zevia to Participate in the 27th Annual ICR Conference
-
E*TRADE from Morgan Stanley Releases Monthly Sector Rotation Study
-
Waystar to Present at J.P. Morgan Healthcare Conference
-
Nextracker to Announce Third Quarter Fiscal 2025 Financial Results on January 28, 2025
-
Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Extreme Networks Schedules Second Quarter 2025 Financial Results Conference Call
-
RLI Fourth Quarter earnings release & teleconference
-
ServiceTitan Reschedules Q3 FY25 Earnings Conference Call In Observance of The National Day of Mourning
-
Waldencast Announces Participation in the ICR Conference 2025
-
Roadzen Inc. Announces Closing of Public Offering
-
HF Foods Group Inc. to Participate in the 2025 ICR Conference
-
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
-
Citizens Financial Group Announces Fourth Quarter and Full Year 2024 Earnings Conference Call Details
-
Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages DMC Global Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BOOM
-
Marcelo Claure and Harvard Growth Lab to Develop New Research Agenda to Diagnose the Current Crisis and Drive Economic Growth in Bolivia
-
MARPAI ANNOUNCES SECOND TRANCHE OF NON-DILUTIVE GROWTH FUNDING WITH UP TO $5 MILLION FROM JGB
-
Guanacaste Art Gallery MÍRAME Fine Art Presents New Wave Painting by Tamarindo Artist Susan Adams
-
Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Arcturus Therapeutics Announces Initiation of Dosing in Phase 2 Multiple Ascending Dose Studies for Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency
-
MSCI Schedules Earnings Call to Review Fourth Quarter and Full Year 2024 Results
-
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Ziegler Closes $56,750,000 Financing for Sun Health Services Obligated Group
-
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Heidrick & Struggles Announces 2025 Global and Regional Leader Appointments
-
RIA Growth Catalyst Partners with WealthFeed to Enhance RIA Prospecting and Acquisition with Best In Class Contact Data
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Mérieux NutriSciences Completes Acquisition of Bureau Veritas' Food Testing Activities in Canada and the U.S.
-
NaaS Technology Inc. to Hold Annual General Meeting on January 25, 2024
-
TCL Unveils Next-Gen NXTPAPER 4.0 Display Technology at CES 2025
-
ImageTrend Acquires biospatial
-
Shure Announces MV7i Smart Microphone + Interface; Learn all about Shure MV7i Mic at B&H
-
First Interstate BancSystem, Inc. Announces Fourth Quarter Earnings Release and Conference Call
-
ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
-
Symbotic Names Dr. James Kuffner as Chief Technology Officer
